Catalyst Pharmaceutical Partners Inc buy Bank of America Co.
Start price
07.03.24
/
50%
€14.95
Target price
07.03.25
€21.15
Performance (%)
32.99%
End price
08.03.25
€19.88
Summary
This prediction ended on 08.03.25 with a price of €19.88. With a performance of 32.99% the BUY prediction by Bank_of_America_Co_ was a big success. Bank_of_America_Co_ has a follow-up prediction for Catalyst Pharmaceutical Partners Inc where he still thinks Catalyst Pharmaceutical Partners Inc is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.391% | 3.391% | 0.932% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€23.55
09.01.25
09.01.25
€29.13
09.01.26
09.01.26
-12.61%
15.12.25
15.12.25
